[Congressional Record Volume 168, Number 84 (Tuesday, May 17, 2022)]
[Senate]
[Page S2550]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




 SENATE RESOLUTION 642--EXPRESSING SUPPORT FOR THE DESIGNATION OF MAY 
  17, 2022, AS ``DIPG PEDIATRIC BRAIN CANCER AWARENESS DAY'' TO RAISE 
  AWARENESS OF, AND ENCOURAGE RESEARCH ON, DIFFUSE INTRINSIC PONTINE 
             GLIOMA TUMORS AND PEDIATRIC CANCERS IN GENERAL

  Mr. RUBIO (for himself, Mr. Reed, Mr. Braun, Mrs. Fischer, Mr. 
Marshall, Mrs. Hyde-Smith, Mr. Casey, and Mrs. Feinstein) submitted the 
following resolution; which was considered and agreed to:

                              S. Res. 642

       Whereas diffuse intrinsic pontine glioma (referred to in 
     this preamble as ``DIPG'') tumors regularly affect 150 to 300 
     children in the United States each year;
       Whereas brain tumors are the leading cause of cancer-
     related death among children;
       Whereas DIPG tumors are the leading cause of pediatric 
     brain cancer deaths;
       Whereas, with respect to a child who is diagnosed with a 
     DIPG tumor and receives treatment for a DIPG tumor, the 
     median amount of time that the child survives after diagnosis 
     is approximately 8 to 11 months;
       Whereas, with respect to an individual who is diagnosed 
     with a DIPG tumor, the rate of survival 5 years after 
     diagnosis is approximately 2 percent;
       Whereas the average age at which a child is diagnosed with 
     a DIPG tumor is between 5 and 10 years, resulting in a life 
     expectancy approximately 70 years shorter than the average 
     life expectancy in the United States; and
       Whereas the prognosis for children diagnosed with DIPG 
     tumors has not improved during the past 50 years: Now, 
     therefore, be it
       Resolved, That the Senate--
       (1) supports--
       (A) designating May 17, 2022, as ``DIPG Pediatric Brain 
     Cancer Awareness Day''; and
       (B) efforts to--
       (i) better understand diffuse intrinsic pontine glioma 
     tumors;
       (ii) develop effective treatments for diffuse intrinsic 
     pontine glioma tumors; and
       (iii) provide comprehensive care for children with diffuse 
     intrinsic pontine glioma tumors and their families; and
       (2) encourages all individuals in the United States to 
     become more informed about--
       (A) diffuse intrinsic pontine glioma tumors;
       (B) pediatric brain cancer in general; and
       (C) challenges relating to research on pediatric cancers 
     and ways to advance such research.

                          ____________________